BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8115426)

  • 1. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.
    Rodríguez de Fonseca F; Gorriti MA; Fernández-Ruiz JJ; Palomo T; Ramos JA
    Pharmacol Biochem Behav; 1994 Jan; 47(1):33-40. PubMed ID: 8115426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
    J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.
    Bonnin A; Fernández-Ruiz JJ; Martín M; Rodríguez de Fonseca F; Hernández ML; Ramos JA
    J Neural Transm Gen Sect; 1993; 92(2-3):81-95. PubMed ID: 8103663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.
    Navarro M; Fernández-Ruiz JJ; de Miguel R; Hernández ML; Cebeira M; Ramos JA
    Behav Brain Res; 1993 Oct; 57(1):37-46. PubMed ID: 8292253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
    Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
    Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
    Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
    Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors.
    Westlake TM; Howlett AC; Ali SF; Paule MG; Scallet AC; Slikker W
    Brain Res; 1991 Mar; 544(1):145-9. PubMed ID: 1649662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.
    Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Vogt LJ; Sim-Selley LJ
    J Neurochem; 1999 Dec; 73(6):2447-59. PubMed ID: 10582605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of cannabinoid binding sites in the brain from early postnatal ages.
    Rodríguez de Fonseca F; Ramos JA; Bonnin A; Fernández-Ruiz JJ
    Neuroreport; 1993 Feb; 4(2):135-8. PubMed ID: 8453049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain.
    Abood ME; Sauss C; Fan F; Tilton CL; Martin BR
    Pharmacol Biochem Behav; 1993 Nov; 46(3):575-9. PubMed ID: 8278434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement.
    Rodríguez de Fonseca F; Cebeira M; Ramos JA; Martín M; Fernández-Ruiz JJ
    Life Sci; 1994; 54(3):159-70. PubMed ID: 8289577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction.
    Chang MC; Berkery D; Schuel R; Laychock SG; Zimmerman AM; Zimmerman S; Schuel H
    Mol Reprod Dev; 1993 Dec; 36(4):507-16. PubMed ID: 8305215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
    Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
    Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evaluation of halogenated delta 8-THC analogs.
    Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A
    Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs.
    García L; de Miguel R; Ramos JA; Fernàndez-Ruiz JJ
    Drug Alcohol Depend; 1996 Nov; 42(3):155-66. PubMed ID: 8912798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
    Freedland CS; Whitlow CT; Miller MD; Porrino LJ
    Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.